Clinical Trials In India: Boom To Stasis To Green Shoots?
This article was originally published in PharmAsia News
Executive Summary
It may be too early to celebrate but some execs in the Indian clinical trials industry are hoping for a slow turnaround as rules are streamlined and the sector gradually syncs its operations with the reformed regulatory checklist.